Literature DB >> 12933765

The SARS epidemic in Hong Kong.

S H Lee1.   

Abstract

Entities:  

Mesh:

Year:  2003        PMID: 12933765      PMCID: PMC1732583          DOI: 10.1136/jech.57.9.652

Source DB:  PubMed          Journal:  J Epidemiol Community Health        ISSN: 0143-005X            Impact factor:   3.710


× No keyword cloud information.
  3 in total

1.  Coronavirus as a possible cause of severe acute respiratory syndrome.

Authors:  J S M Peiris; S T Lai; L L M Poon; Y Guan; L Y C Yam; W Lim; J Nicholls; W K S Yee; W W Yan; M T Cheung; V C C Cheng; K H Chan; D N C Tsang; R W H Yung; T K Ng; K Y Yuen
Journal:  Lancet       Date:  2003-04-19       Impact factor: 79.321

2.  Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong.

Authors:  Christl A Donnelly; Azra C Ghani; Gabriel M Leung; Anthony J Hedley; Christophe Fraser; Steven Riley; Laith J Abu-Raddad; Lai-Ming Ho; Thuan-Quoc Thach; Patsy Chau; King-Pan Chan; Tai-Hing Lam; Lai-Yin Tse; Thomas Tsang; Shao-Haei Liu; James H B Kong; Edith M C Lau; Neil M Ferguson; Roy M Anderson
Journal:  Lancet       Date:  2003-05-24       Impact factor: 79.321

3.  SARS: experience at Prince of Wales Hospital, Hong Kong.

Authors:  Brian Tomlinson; Clive Cockram
Journal:  Lancet       Date:  2003-05-03       Impact factor: 79.321

  3 in total
  23 in total

1.  Reflecting on COVID-19: The Hong Kong Experience of Flattening the Curve Without Lockdown.

Authors:  Herbert H Loong
Journal:  J Immunother Precis Oncol       Date:  2020-08-05

2.  A comparative epidemiologic analysis of SARS in Hong Kong, Beijing and Taiwan.

Authors:  Eric H Y Lau; C Agnes Hsiung; Benjamin J Cowling; Chang-Hsun Chen; Lai-Ming Ho; Thomas Tsang; Chiu-Wen Chang; Christl A Donnelly; Gabriel M Leung
Journal:  BMC Infect Dis       Date:  2010-03-06       Impact factor: 3.090

Review 3.  Transmission modes of severe acute respiratory syndrome coronavirus 2 and implications for infection control: a review.

Authors:  Sean Wei Xiang Ong; Kristen K Coleman; Po Ying Chia; Koh Cheng Thoon; Surinder Pada; Indumathi Venkatachalam; Dale Fisher; Yian Kim Tan; Boon Huan Tan; Oon Tek Ng; Brenda Sze Peng Ang; Yee-Sin Leo; Michelle Su Yen Wong; Kalisvar Marimuthu
Journal:  Singapore Med J       Date:  2020-07-30       Impact factor: 3.331

4.  Repeated Exposure to Subinfectious Doses of SARS-CoV-2 May Promote T Cell Immunity and Protection against Severe COVID-19.

Authors:  Maria Laura De Angelis; Federica Francescangeli; Rachele Rossi; Alessandro Giuliani; Ruggero De Maria; Ann Zeuner
Journal:  Viruses       Date:  2021-05-22       Impact factor: 5.048

Review 5.  Human coronaviruses: insights into environmental resistance and its influence on the development of new antiseptic strategies.

Authors:  Chloé Geller; Mihayl Varbanov; Raphaël E Duval
Journal:  Viruses       Date:  2012-11-12       Impact factor: 5.048

6.  Index patient and SARS outbreak in Hong Kong.

Authors:  Raymond S M Wong; David S Hui
Journal:  Emerg Infect Dis       Date:  2004-02       Impact factor: 6.883

Review 7.  Overview: The history and pediatric perspectives of severe acute respiratory syndromes: Novel or just like SARS.

Authors:  Kam Lun Hon; Karen Ka Yan Leung; Alexander K C Leung; Siddharth Sridhar; Suyun Qian; So Lun Lee; Andrew A Colin
Journal:  Pediatr Pulmonol       Date:  2020-06-01

8.  Severe acute respiratory syndrome coronavirus on hospital surfaces.

Authors:  Scott F Dowell; James M Simmerman; Dean D Erdman; Jiunn-Shyan Julian Wu; Achara Chaovavanich; Massoud Javadi; Jyh-Yuan Yang; Larry J Anderson; Suxiang Tong; Mei Shang Ho
Journal:  Clin Infect Dis       Date:  2004-08-11       Impact factor: 9.079

9.  Emergence of SARS-like coronavirus in China: An update.

Authors:  Zhipeng Zhang; Kangpeng Xiao; Xu Zhang; Ayan Roy; Yongyi Shen
Journal:  J Infect       Date:  2020-03-13       Impact factor: 6.072

10.  COVID-19: what is next for public health?

Authors:  David L Heymann; Nahoko Shindo
Journal:  Lancet       Date:  2020-02-13       Impact factor: 79.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.